Researchers and biomedical engineers from Dartmouth Health, Dartmouth Cancer Center and the Thayer School of Engineering at ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

A collaborative research team has successfully developed a novel fluorescent probe, SLY (Sialyl Lewis Yellow), capable of ...

It has been over 60 years since Osamu Shimomura et al. discovered Green Fluorescent Protein (GFP)1. Since then, the color ...

Cancer cells can acquire energy-generating structures called mitochondria from nearby nerve cells, which seems to aid their ...

Researchers are testing new treatments for IDH mutant gliomas, including targeted and immunotherapies, to improve survival or quality of life. Learn more.

Gliomas are tumors that grow from glial cells, which are a type of cell that support and protect nerve cells in the brain and spinal cord. There are multiple types of gliomas that may start in ...

It is evidenced that the capability of ultrashort pulsed electric fields to downregulate the intercellular adherence, as well as suppress the epithelial-mesenchymal transition, a key process of ...

A new study suggests that never-seen-before stem cells in the human retina can restore vision in mice with a common eye disorder. But more work is needed to translate the treatment to people.

AI Model Detects Brain Tumor Missed During Surgery in 10 Seconds FastGlioma detects residual brain tumor cells in seconds, improving precision and reducing tumor recurrence risks.

CLD-101 is a novel stem cell-based treatment that delivers oncolytic viruses to tumors, which may benefit patients with newly diagnosed high-grade glioma.

Targeting glioma stem cells with thyroid hormone suppression: Phase 1/2 trial of methimazole in patients with progressive grade 4 gliomas.